• LDH Cytotoxicity Assay Kit: Precision in Cell Damage Quantif

  2026-04-29

  The LDH Cytotoxicity Assay Kit enables robust, quantitative cell cytotoxicity measurement with high sensitivity and non-radioactive safety, streamlining workflows in cancer and nanomaterial research. Its proven compatibility with advanced biocompatibility studies and apoptosis detection makes it a benchmark tool for reliable experimental outcomes.

• BCA Protein Assay Kit: Precision Protein Quantification for

  2026-04-29

  The APExBIO BCA Protein Assay Kit empowers researchers tackling complex blood–brain barrier (BBB) mechanisms, offering unrivaled sensitivity and reproducibility for protein quantification in demanding models. Drawing from recent advances in endothelial pyroptosis studies, this guide delivers actionable workflow enhancements, troubleshooting strategies, and contextualizes the assay’s centrality to translational neurovirology.

• Cyclophosphamide: Applied Protocols in Cancer and Immune Res

  2026-04-28

  Cyclophosphamide, a gold-standard alkylating chemotherapeutic agent, enables precise apoptosis induction and immune modulation in cancer and transplantation research. This guide delivers actionable protocols, troubleshooting insights, and workflow enhancements—empowering your lab with APExBIO’s rigorously validated Cyclophosphamide (SKU A2343) for reproducible, publication-grade data.

• Homoharringtonine as a Broad-Spectrum SARS-CoV-2 Inhibitor

  2026-04-28

  This study demonstrates that homoharringtonine, a cytotoxic alkaloid with established use in leukemia research, robustly inhibits SARS-CoV-2 replication in vitro and in vivo. The findings highlight its rapid action in viral clearance and potential as a first-line agent against future coronavirus outbreaks.

• Methyl-β-cyclodextrin: Technical Guide for Cholesterol Extra

  2026-04-27

  Methyl-β-cyclodextrin (SKU C6939) enables precise extraction of membrane cholesterol and disruption of lipid rafts in cell-based and biochemical research workflows. Its high solubility and purity support reproducible results in studies of membrane dynamics and cholesterol-dependent signaling. It is strictly for laboratory use and not appropriate for diagnostic or clinical applications.

• Concerted Screening Reveals TSA Potentiates PDA Chemotherapy

  2026-04-27

  This study introduces a rapid, dual-phase screening approach using Rgs16::GFP expression to identify chemotherapeutic combinations for pancreatic ductal adenocarcinoma (PDA). The work demonstrates that Trichostatin A (TSA), an HDAC inhibitor, significantly augments established PDA therapies, offering new avenues for targeting early neoplastic lesions.

• EdU Flow Cytometry (Cy5): Powering Translational Cell Cycle

  2026-04-26

  This article delivers a strategic perspective for translational researchers, uniting mechanistic insight into cell cycle S-phase measurement with actionable guidance for experimental design. Using the APExBIO EdU Flow Cytometry Assay Kits (Cy5) as a benchmark, we demonstrate how next-generation click chemistry DNA synthesis detection can unlock new frontiers in biomarker-driven wound healing and oncology research. Drawing on recent evidence for m7G-dependent cell proliferation in diabetic foot ulcers, we provide protocol parameters, competitive differentiation, and a vision for high-impact translational workflows.

• Patient-Derived Gastric Cancer Assembloids Enhance Drug Test

  2026-04-25

  This study introduces a patient-derived gastric cancer assembloid model that integrates matched tumor organoids and stromal cell subpopulations, more accurately mimicking the tumor microenvironment. The model reveals how stromal diversity influences gene expression and drug responsiveness, enabling more predictive preclinical testing and the investigation of resistance mechanisms.

• Baicalin Methyl Ester: Integrative Mechanisms in Intestinal

  2026-04-24

  Explore how Baicalin methyl ester, an esterified derivative of baicalin, uniquely modulates inflammatory signaling and tight junction repair in LPS-induced intestinal barrier damage research. This article offers a mechanistic deep dive and practical protocol guidance for advanced intestinal inflammation models.

• Rotavirus Infection Suppresses Nrf2 Redox Defense Pathways

  2026-04-24

  This study demonstrates that progressive rotavirus infection actively downregulates the redox-sensitive transcription factor Nrf2 and its target genes, undermining the host antioxidant defense mechanism. These findings clarify how viral manipulation of Nrf2 signaling disrupts cellular redox homeostasis, with implications for antiviral and stress response research.

• SU6656 Src Tyrosine Kinases Inhibitor: Redefining Platelet E

  2026-04-23

  Explore the science and translational impact of SU6656, a potent Src tyrosine kinases inhibitor, in both ex vivo platelet engineering and radiotherapy sensitization. This article delivers protocol-critical insights and uniquely bridges stem cell innovation with advanced oncology research.

• Tacalcitol Monohydrate: Advancing Colorectal and Psoriasis R

  2026-04-23

  Tacalcitol monohydrate, a synthetic analog of vitamin D3, delivers unique versatility for both dermatological and oncological research. Its data-backed synergy with 5-fluorouracil and robust NGF induction make it a go-to reagent for precision workflows and protocol innovation.

• ECL Western Blotting Substrate: Technical Protocol & QC Guid

  2026-04-22

  ECL Western Blotting Substrate (SKU K2187) provides a sensitive, nonradioactive solution for detecting HRP-labeled proteins in Western blot assays—offering high signal intensity with low background. It is designed for protein detection by chemiluminescence in molecular and cancer biology workflows, but is not suitable for fluorescent or radioisotopic detection applications.

• Entinostat (MS-275): Strategic HDAC Inhibition in Oncology

  2026-04-22

  This article delivers a deep-dive into the mechanistic, methodological, and strategic dimensions of Entinostat (MS-275, SNDX-275) in translational cancer research. It guides researchers through the latest evidence on selective HDAC1/3 inhibition, highlights critical insights from advanced in vitro assay design and clinical translation, and positions Entinostat as a pivotal tool for precision oncology workflows. Distinct from standard product summaries, this piece integrates recent doctoral findings, competitive landscape analysis, and actionable workflow parameters, advancing the conversation on robust, reproducible epigenetic modulation for both preclinical and translational endpoints.

• Cy3-dCTP: Enabling Precision Fluorescent DNA Labeling in Enz

  2026-04-21

  Explore how Cy3-dCTP (Cyanine 3-deoxycytidine triphosphate) advances direct enzymatic DNA and cDNA labeling through integration with next-generation DNA frameworks. This article offers in-depth analysis, protocol guidance, and unique insights for maximizing labeling efficiency in cutting-edge molecular biology workflows.

408 records 17/28 page Previous Next First page 上5页 1617181920 下5页 Last page